Oprozomib (PR-047) is an orally bioavailable and selective peptide epoxyketone proteasome inhibitor with IC50s of 36 and 82 nM for proteasome (beta5) and immunoproteasome (LMP7), respectively. Oprozomib (ONX 0912) induces apoptosis in MM cells[1].
Molecular Weight:
532.61
Purity:
99.76
CAS Number:
[935888-69-0]
Formula:
C25H32N4O7S
Target:
Apoptosis,Autophagy,Proteasome
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
